Edition:
United Kingdom

ImmuCell Corp (ICCC.OQ)

ICCC.OQ on NASDAQ Stock Exchange Capital Market

8.75USD
15 Dec 2017
Change (% chg)

$-0.20 (-2.23%)
Prev Close
$8.95
Open
$8.92
Day's High
$8.92
Day's Low
$8.75
Volume
5,088
Avg. Vol
2,331
52-wk High
$9.25
52-wk Low
$5.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 2.00 -0.068
Jun '17 1.75 -0.045
Mar '17 3.54 0.118
FY 2016 Dec '16 2.21 0.009
Sep '16 1.97 0.008
Jun '16 2.38 -0.002
Mar '16 2.99 0.115
FY 2015 Dec '15 2.69 0.095
Sep '15 2.47 0.110
Jun '15 1.96 0.030
Mar '15 3.10 0.152
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 77.69 88.66 32.93
P/E High - Last 5 Yrs. 138.89 290.77 45.62
P/E Low - Last 5 Yrs. 18.91 93.67 24.34
Beta 1.12 0.85 0.88
Price to Sales (TTM) 3.73 100.68 5.40
Price to Book (MRQ) 1.68 13.50 5.38
Price to Tangible Book (MRQ) 1.77 13.43 6.78
Price to Cash Flow (TTM) 27.63 76.24 23.45
% Owned Institutions 15.67 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) 0.00 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -26.35 433.88 9.00
Sales (TTM) vs TTM 1 Yr. Ago -10.00 75.04 5.38
Sales - 5 Yr. Growth Rate 13.30 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -1,956.62 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -71.60 -- --
EPS - 5 Yr. Growth Rate -- 43.18 10.79
Capital Spending - 5 Yr. Growth Rate 71.22 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.28 1.68 2.18
Current Ratio (MRQ) 1.89 5.36 2.98
LT Debt to Equity (MRQ) 17.73 18.93 11.56
Total Debt to Equity (MRQ) 20.91 20.59 15.81
Interest Coverage (TTM) 19.55 -111.94 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 58.01 38.73 54.83
Gross Margin - 5 Yr. Avg. 57.36 51.18 52.40
EBITD Margin (TTM) 17.63 -- --
EBITD - 5 Yr. Avg 14.53 -261.13 15.24
Operating Margin (TTM) 8.68 -556.69 7.76
Operating Margin - 5 Yr. Avg. 7.82 -279.31 10.75
Pre-Tax Margin (TTM) 7.16 -529.93 8.57
Pre-Tax Margin - 5 Yr. Avg. 7.65 -279.05 11.17
Net Profit Margin (TTM) 4.55 -531.37 4.88
Net Profit Margin - 5 Yr. Avg. 4.54 -282.22 7.47
Effective Tax Rate (TTM) 36.51 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. 40.57 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 25,316,769 864,680,848
Net Income/Employee (TTM) -- 3,332,346 101,718,394
Receivable Turnover (TTM) 11.47 21.54 5.76
Inventory Turnover (TTM) 2.07 2.01 3.34
Asset Turnover (TTM) 0.39 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 1.77 -0.77 11.00
Return on Assets - 5 Yr. Avg. 2.69 -0.26 12.43
Return on Investment (TTM) 1.99 2.36 14.46
Return on Investment - 5 Yr. Avg. 2.89 2.98 16.28
Return on Equity (TTM) 2.36 2.96 16.05
Return on Equity - 5 Yr. Avg. 3.33 6.41 17.51
  1 Year 3 Year 5 Year
Sales % -6.69 16.69 13.30
EPS (TTM) % -69.91 46.65 --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ImmuCell Corp

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 13.35%
# of Holders: 17
Total Shares Held: 674,470
3 Mo. Net Change: -116,603
# New Positions: 2
# Closed Positions: 2
# Increased Positions: 9
# Reduced Positions: 4
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.